What is a pharma ETF?

A pharma ETF is an exchange-traded fund that invests in a basket of pharmaceutical companies. It typically tracks a sector index, such as the Nifty Pharma Index, and offers diversified exposure through a single listed product.

What is the best pharmaceutical ETF?

There is no single best option because performance depends on costs, liquidity, tracking quality and index structure. Investors comparing a pharma ETF list can review these factors before evaluating different sector-focused products. Disclaimer: This information is for educational purposes only and should not be considered investment advice.

Is there any pharma ETF in India?

Yes. A Nifty Pharma ETF such as the Nippon India Nifty Pharma ETF tracks the Nifty Pharma Index and provides exposure to listed pharmaceutical companies through an exchange-traded structure. Disclaimer: This information is for educational purposes only and should not be considered investment advice.

Is pharma ETF a good investment?

A pharmaceutical ETF provides focused exposure to the pharma sector, but suitability depends on regulation, export demand, valuations and investment horizon. Like other sector funds, it can be more concentrated than broad-market ETFs. Disclaimer: This information is for educational purposes only and should not be considered investment advice.

How is Nippon India Nifty Pharma ETF performing?

Investors can review pharma index funds and ETFs by comparing returns across multiple periods rather than relying on a single figure. Performance generally reflects movements in the underlying pharma index, less expenses and tracking differences.

What does a pharma ETF invest in?

A pharma ETF invests in listed drug makers, formulation companies, API producers and other pharmaceutical businesses, depending on its benchmark. A list of pharma ETF in India can help compare the underlying index and portfolio structure.

How is a pharma ETF different from a healthcare sector ETF?

A pharma ETF focuses mainly on pharmaceutical companies, while a healthcare ETF can also include hospitals, diagnostics, medical devices and healthcare service providers, giving it broader industry exposure.

Where can I compare Pharma ETFs?

Investors can compare a pharma ETF list using factors such as index methodology, AUM, expense ratio, tracking error and liquidity. Tickertape can also help review available ETFs and their key metrics.

Pharma ETFs: Top Pharma Index Funds in India (2026)

India supplies about 20% of global generic medicines by volume and around 60% of global vaccines. The domestic pharmaceutical market is estimated at $60 bn in FY26 and projected to reach $130 bn by 2030. Pharma ETFs offer exchange-traded exposure to this sector by tracking indices such as the Nifty Pharma Index.

List of Best Pharma ETFs in India 2026

Pharma ETF Stock Screener

Pharma ETF Stock Screener: Analyse & Filter Indian Stocks on Tickertape

Created by

@tickertape tickertape

Showing 1 - 1 of 1 results

last updated at 9:45 PM IST

	NameStock (1)↓	↓Sub-SectorSub-Sector↓	↓Market CapMarket Cap↓	↓Close PriceClose Price↓	↓PE RatioPE Ratio↓	↓1D Return1D Return↓	↓1M Return1M Return↓	↓6M Return6M Return↓	↓1Y Return1Y Return↓	↓PB RatioPB Ratio↓	↓Return on EquityReturn on Equity↓	↓ROCEROCE↓	↓Dividend YieldDiv Yield↓	↓Debt to EquityDebt to Equity↓	↓Volatility vs NiftyVolatility vs Nifty↓
1.	Nippon India Nifty Pharma ETF PHARMABEES	EquityEquity	1,266.641,266.64	27.8727.87	--	-0.14-0.14	2.652.65	15.8815.88	21.4921.49	--	--	--	--	--	1.031.03

Edit Filters

Analyse Pharma ETFs further

Disclaimer: Please note that the above table is for informational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.

Selection criteria: Based on publicly available information | Sorted by market capitalisation from highest to lowest.

Overview of Top Pharma ETFs in India

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF is an exchange-traded fund that follows the Nifty Pharma Index. It buys the same major pharma stocks in the index, such as Sun Pharma, Cipla, Dr. Reddy’s, Divi’s Labs, and Lupin. It trades on the stock exchange like a regular share, so you get easy and low-cost access to a diversified basket of pharma companies through one investment.

What are Pharma ETFs?

Pharma ETFs in India are exchange-traded funds that invest in a basket of Indian pharmaceutical and healthcare companies. They track sector-specific indices like the Nifty Pharma Index or the Nifty Healthcare Index and trade on the stock exchange like any other stock.

How to Invest in Pharma ETFs?

Here's how you can invest in Pharma ETFs using Tickertape -

Create an account on the Tickertape or log in if you already have one.
Open Tickertape Stock Screener
Filter Pharma ETFs screener based on various parameters such as market cap, close price, past returns and more. You can review this data to evaluate each ETF’s performance trends and determine whether they align with your investment thesis.
Once you’ve decided on an ETF, you can place a buy order through your brokerage account linked to Tickertape.

You can also stay updated on alerts and announcements for your favourite stocks with Tickertape Alerts. Further, you can analyse your overall portfolio and potential red flags in it by connecting it to Tickertape. Check out detailed analysis of your portfolio now!

Advantages of Investing in Pharma ETFs in India

Broad Pharma Exposure

Nippon India Nifty Pharma ETF tracks a 20-stock pharmaceutical index, spreading exposure across multiple drugmakers rather than one company. As of March 2026, the ETF managed ₹1,248 cr in assets.

Low Tracking Error

Nippon India Nifty Pharma ETF reported a tracking error of 0.02% in March 2026. This indicates close benchmark replication, helping investors access sector performance with relatively limited deviation from the underlying index.

Low Cost

Nippon India Nifty Pharma ETF charged a 0.21% expense ratio in March 2026. Its passive structure avoids active stock selection, keeping ongoing fund costs relatively contained while maintaining pharmaceutical-sector exposure.

Healthcare Breadth

Motilal Oswal BSE Healthcare ETF extends beyond drug manufacturers. In March 2026, 76.3% of its portfolio was pharmaceuticals and biotechnology, while 23.2% was healthcare services, broadening exposure across different healthcare businesses.

Export Participation

India’s pharmaceutical exports reached $31.13 bn in FY26, with formulations and biologicals contributing 79.26%. Pharma ETFs offer indirect exposure to listed companies in this expanding export-oriented industry and the global medicines market.

Download Now

Risks of Investing in Pharma ETFs in India

Sector Concentration

Pharma ETFs remain concentrated in one industry. Motilal Oswal BSE Healthcare ETF held 99.9% in healthcare in March 2026, so regulatory setbacks, pricing pressure, or weak sector earnings can affect most holdings at once.

Stock Concentration

Nippon India Nifty Pharma ETF follows a free-float weighted index where individual stocks can carry meaningful weights. This can make ETF returns sensitive to earnings or regulatory developments at the largest pharmaceutical companies.

Regulatory Risk

US regulatory actions can materially affect Indian drugmakers. In FY26, the FDA increased unannounced inspections in India to 87% year-to-date, significantly raising compliance scrutiny for export-focused pharmaceutical companies.

Tracking Risk

Even passive pharma ETFs can lag their benchmarks after expenses and portfolio adjustments. Motilal Oswal BSE Healthcare ETF returned 1.16% over one year to March 2026 versus 1.40% for its benchmark.

Liquidity Risk

Smaller healthcare ETFs can have thinner secondary-market trading. Motilal Oswal BSE Healthcare ETF had AUM of only ₹40.68 cr in March 2026, which can widen bid-ask spreads during transactions.

Factors to Consider Before Investing in Pharma ETFs

Index Design

Nifty Pharma contains 20 companies and caps individual stock weights at 33%, with the top three capped at 62%. Investors should understand this weighting structure because larger constituents still drive a substantial share of returns.

FDA Compliance

The FDA increased unannounced inspections in India to 87% of inspections year-to-date in FY26. Inspection outcomes, warning letters and import restrictions can materially affect revenue expectations for export-dependent pharmaceutical companies.

Currency Movements

Indian pharma exporters earn significant revenue overseas, making rupee movements relevant. A weaker rupee can support translated export revenue, while appreciation may reduce the rupee value of foreign-currency sales for constituent companies.

Tracking and Cost

Nippon India Nifty Pharma ETF reported a 0.21% TER and 0.02% tracking error in March 2026. Comparing both metrics helps assess how efficiently an ETF converts benchmark performance into investor returns.

Trading Liquidity

AUM and exchange activity differ materially across pharma ETFs. Nippon India Nifty Pharma ETF managed ₹1,248 cr in March 2026, while Motilal Oswal BSE Healthcare ETF held about ₹41 cr.

Taxation on Pharma ETFs

Pharma ETFs attract capital gains tax based on how long the investment is held. Short-term and long-term gains are taxed separately.

Holding Period	Tax Treatment
Short-Term (< 12 months )	Gains taxed at a flat rate of 20% (increased from the previous 15%).
Long-Term (> 12 months)	Gains taxed at 12.5%. Exemption applies to the first ₹1.25 Lakh of long-term gains across all equity assets in a financial year.

Conclusion

Pharma ETFs in India offer a simple way to track the pharmaceutical sector without picking individual stocks. They provide transparent exposure to leading drug makers and reflect broader sector trends, but they also carry risks such as regulatory changes, export pressure, and currency movement. Before investing in a pharma ETF, it helps to review sector cycles, index composition, and costs. Checking options in the Nifty Pharma ETF list and comparing them using tools like the Tickertape Stock Screener can make it easier to understand which pharma ETF India aligns with a specific investment view.

Popular Stock Collections

Popular Mutual Fund Collections

Frequently Asked Questions on Pharma ETFs

What is a pharma ETF?
A pharma ETF is an exchange-traded fund that invests in a basket of pharmaceutical companies. It typically tracks a sector index, such as the Nifty Pharma Index, and offers diversified exposure through a single listed product.
What is the best pharmaceutical ETF?
There is no single best option because performance depends on costs, liquidity, tracking quality and index structure. Investors comparing a pharma ETF list can review these factors before evaluating different sector-focused products.
Disclaimer: This information is for educational purposes only and should not be considered investment advice.
Is there any pharma ETF in India?
Yes. A Nifty Pharma ETF such as the Nippon India Nifty Pharma ETF tracks the Nifty Pharma Index and provides exposure to listed pharmaceutical companies through an exchange-traded structure.
Disclaimer: This information is for educational purposes only and should not be considered investment advice.
Is pharma ETF a good investment?
A pharmaceutical ETF provides focused exposure to the pharma sector, but suitability depends on regulation, export demand, valuations and investment horizon. Like other sector funds, it can be more concentrated than broad-market ETFs.
Disclaimer: This information is for educational purposes only and should not be considered investment advice.
How is Nippon India Nifty Pharma ETF performing?
Investors can review pharma index funds and ETFs by comparing returns across multiple periods rather than relying on a single figure. Performance generally reflects movements in the underlying pharma index, less expenses and tracking differences.
What does a pharma ETF invest in?
A pharma ETF invests in listed drug makers, formulation companies, API producers and other pharmaceutical businesses, depending on its benchmark. A list of pharma ETF in India can help compare the underlying index and portfolio structure.
How is a pharma ETF different from a healthcare sector ETF?
A pharma ETF focuses mainly on pharmaceutical companies, while a healthcare ETF can also include hospitals, diagnostics, medical devices and healthcare service providers, giving it broader industry exposure.
Where can I compare Pharma ETFs?
Investors can compare a pharma ETF list using factors such as index methodology, AUM, expense ratio, tracking error and liquidity. Tickertape can also help review available ETFs and their key metrics.

Disclaimer: This article is for informational purposes only. The content of the article including securities/investment products mentioned if any, should not in any manner be construed as an investment advice, recommendation, offer, solicitation to buy/hold/sell any securities/investment products. The securities quoted if any, are for illustration only and are not recommendatory. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered financial advisor before investing.